After treatment, hASC did not exhibit a significant change in metabolic activity as measured by MTT assay
placebo on MACE was observed, although the overall incidence of prior HF was low
No, injecting semaglutide in the same location repeatedly can cause lipodystrophy, where fatty tissue becomes damaged or thickened
They work through different biological mechanisms and are not interchangeable
Isabel Krug et al., Beyond Weight Loss: GLP1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes , 17 Nutrients 3735, 5 (2025), available at : (last visited Apr
GLP-1 then sends the message to the pancreas to produce insulin, which slows the emptying of the stomach and messages to the brain that youre full